Accessibility Menu
Sensus Healthcare Stock Quote

Sensus Healthcare (NASDAQ: SRTS)

$3.84
(1.9%)
+0.07
Price as of December 18, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$3.84
Daily Change
(1.9%) +$0.07
Day's Range
$3.75 - $3.90
Previous Close
$3.84
Open
$3.78
Beta
0.90
Volume
33,337
Average Volume
106,351
Market Cap
$62M
Market Cap / Employee
$3.77M
52wk Range
$3.03 - $9.08
Revenue
N/A
Gross Margin
0.48%
Dividend Yield
N/A
EPS
-$0.18
CAPs Rating
N/A
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Sensus Healthcare Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
SRTS-48.11%+6.67%+1.3%-36%
S&P+11.09%+81.2%+12.62%+210%
Advertisement

Sensus Healthcare Company Info

Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

News & Analysis

Financial Health

General

Q3 2025YOY Change
Revenue$6.88M-22.1%
Gross Profit$2.71M-48.2%
Gross Margin39.41%-19.9%
Market Cap$51.62M-45.7%
Market Cap / Employee$955.96K0.0%
Employees5454.3%
Net Income-$943.00K-177.6%
EBITDA-$2,410.00K-250.9%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$24.45M8.4%
Accounts Receivable$9.34M-45.0%
Inventory14.45.0%

Liabilities

Q3 2025YOY Change
Long Term Debt$277.00K-38.6%
Short Term Debt$257.00K28.5%

Ratios

Q3 2025YOY Change
Return On Assets-5.09%-22.0%
Return On Invested Capital9.59%3.5%

Cash Flow

Q3 2025YOY Change
Free Cash Flow$2.29M-36.6%
Operating Free Cash Flow$2.30M-41.9%

Valuation

MetricQ2 2024Q3 2024Q4 2024Q1 2025YoY Change
Price to Earnings13.0710.1517.0243.04223.36%
Price to Book2.101.401.470.99-44.84%
Price to Sales2.721.962.061.44-37.30%
Price to Tangible Book Value2.101.401.470.99-44.84%
Price to Free Cash Flow TTM45.3416.7022.1523.65-
Enterprise Value to EBITDA49.63-23.54-31.25-11.34-124.84%
Free Cash Flow Yield2.2%6.0%4.5%4.2%-
Return on Equity12.7%3.5%-1.6%-5.7%-130.26%
Total Debt$602.00K$654.00K$595.00K$534.00K-17.97%

No results found

No podcast episodes available.

Advertisement

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.